×
Back to Agenda
More Nuanced Clinical Outcomes from Person-Generated Health Data: The New Frontier
Session Chair(s)
Nancy Dreyer, MPH, FISPE
Founder, Dreyer Strategies LLC, United States
Person-generated data offers nuanced effectiveness measures for clinical and regulatory decision-making for new medical products, like the wearable-derived digital clinical outcome assessment for Duchenne muscular dystrophy. What's next?
Learning Objective : Describe practical applications of person-generated health data, and key business and regulatory perspectives on opportunities and challenges; Explain the value of this type of information to patients, clinicians, and colleagues to help inform decision-making.
Speaker(s)
Panelist
CSO RWE and SVP AAIS, IQVIA, United States
Panelist
Director, Office of Drug Evaluation Sciences, OND, CDER, FDA, United States
Panelist
Associate Director, Global Regulatory Policy & Intelligence , Johnson & Johnson, United States
Have an account?